These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 28534428)

  • 21. Trail Making Test: normative data for the Lebanese adult population.
    Abi Chahine J; Rammal S; Fares Y; Abou Abbas L
    Clin Neuropsychol; 2020 Dec; 34(sup1):29-42. PubMed ID: 31888415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropsychological Profiles in Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases.
    Hessen E; Stav AL; Auning E; Selnes P; Blomsø L; Holmeide CE; Johansen KK; Eliassen CF; Reinvang I; Fladby T; Aarsland D
    J Parkinsons Dis; 2016 Apr; 6(2):413-21. PubMed ID: 27061068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-validation of the Trail Making Test as a non-memory-based embedded performance validity test among veterans with and without cognitive impairment.
    Peak AM; Marceaux JC; Chicota-Carroll C; Soble JR
    J Clin Exp Neuropsychol; 2024 Feb; 46(1):16-24. PubMed ID: 38007610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Instrumental activities of daily living are impaired in Parkinson's disease patients with mild cognitive impairment.
    Pirogovsky E; Schiehser DM; Obtera KM; Burke MM; Lessig SL; Song DD; Litvan I; Filoteo JV
    Neuropsychology; 2014 Mar; 28(2):229-37. PubMed ID: 24417192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Normative Data for Verbal Fluency, Trail Making, and Rey-Osterrieth Complex Figure Tests on Monolingual Spanish-Speaking Older Adults.
    García-Herranz S; Díaz-Mardomingo MC; Suárez-Falcón JC; Rodríguez-Fernández R; Peraita H; Venero C
    Arch Clin Neuropsychol; 2022 Jul; 37(5):952-969. PubMed ID: 34984432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study.
    Kalbe E; Rehberg SP; Heber I; Kronenbuerger M; Schulz JB; Storch A; Linse K; Schneider C; Gräber S; Liepelt-Scarfone I; Berg D; Dams J; Balzer-Geldsetzer M; Hilker R; Oberschmidt C; Witt K; Schmidt N; Mollenhauer B; Trenkwalder C; Spottke A; Roeske S; Wittchen HU; Riedel O; Dodel R
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1099-105. PubMed ID: 27401782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Trail Making Test.
    Llinàs-Reglà J; Vilalta-Franch J; López-Pousa S; Calvó-Perxas L; Torrents Rodas D; Garre-Olmo J
    Assessment; 2017 Mar; 24(2):183-196. PubMed ID: 26318386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measuring executive dysfunction in Parkinson's disease: Reliability and validity of the Spanish version of Frontal Assessment Battery (FAB-E).
    Hurtado-Pomares M; Terol-Cantero MC; Sánchez-Pérez A; Leiva-Santana C; Peral-Gómez P; Valera-Gran D; Navarrete-Muñoz EM
    PLoS One; 2018; 13(11):e0207698. PubMed ID: 30452476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing the utility of the Movement Disorder Society Task Force Level 1 diagnostic criteria for mild cognitive impairment in Parkinson's disease.
    Szeto JY; Mowszowski L; Gilat M; Walton CC; Naismith SL; Lewis SJ
    Parkinsonism Relat Disord; 2015 Jan; 21(1):31-5. PubMed ID: 25465744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyloid-β and α-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease.
    Stav AL; Aarsland D; Johansen KK; Hessen E; Auning E; Fladby T
    Parkinsonism Relat Disord; 2015 Jul; 21(7):758-64. PubMed ID: 25971633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regression-Based Normative Data for Independent and Cognitively Active Spanish Older Adults: Digit Span, Letters and Numbers, Trail Making Test and Symbol Digit Modalities Test.
    Iñesta C; Oltra-Cucarella J; Bonete-López B; Calderón-Rubio E; Sitges-Maciá E
    Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Symbol-Digit Modalities Test in Mild Cognitive Impairment: Evidence from Parkinson's Disease Patients.
    Pascoe M; Alamri Y; Dalrymple-Alford J; Anderson T; MacAskill M
    Eur Neurol; 2018; 79(3-4):206-210. PubMed ID: 29597229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Italian version of the alternative form of Parkinson's Disease-Cognitive Rating Scale (PD-CRS/AF): normative values from 260 Italian healthy subjects.
    D'Iorio A; Maggi G; Baiano C; Santangelo G
    Neurol Sci; 2022 Jun; 43(6):3613-3620. PubMed ID: 35083571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment.
    Noh SW; Han YH; Mun CW; Chung EJ; Kim EG; Ji KH; Seo JH; Kim SJ
    J Neurol Sci; 2014 Dec; 347(1-2):210-3. PubMed ID: 25451006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternative type of the trail making test in nonnative English-speakers: the trail making test-black & white.
    Kim HJ; Baek MJ; Kim S
    PLoS One; 2014; 9(2):e89078. PubMed ID: 24551221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regression-based normative data and equivalent scores for Trail Making Test (TMT): an updated Italian normative study.
    Siciliano M; Chiorri C; Battini V; Sant'Elia V; Altieri M; Trojano L; Santangelo G
    Neurol Sci; 2019 Mar; 40(3):469-477. PubMed ID: 30535956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.
    Hobson P; Meara J
    Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and Subtypes of Mild Cognitive Impairment in Parkinson's Disease.
    Lawrence BJ; Gasson N; Loftus AM
    Sci Rep; 2016 Sep; 6():33929. PubMed ID: 27650569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterizing mild cognitive impairment in Parkinson's disease.
    Dalrymple-Alford JC; Livingston L; MacAskill MR; Graham C; Melzer TR; Porter RJ; Watts R; Anderson TJ
    Mov Disord; 2011 Mar; 26(4):629-36. PubMed ID: 21287603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.